@article{b89d2cff1a1b4decbd1b73a10ee58669,
title = "New Clues to Preclinical Alzheimer{\textquoteright}s Disease",
author = "Rosenberg, {Paul B.} and Lyketsos, {Constantine G.}",
note = "Funding Information: Dr. Rosenberg has received research support from AbbVie, the Alzheimer{\textquoteright}s Association, Eli Lilly, and the National Institute on Aging; he has served as a consultant on advisory boards for AbbVie, Avanir, Lundbeck, and Otsuka; and he has received travel support from Avanir and Otsuka. Dr. Lyketsos has received grant support (research or CME) from the Associated Jewish Federation of Baltimore, AstraZeneca, Bristol-Myers Squibb, Eisai, Elan, Eli Lilly, Forest, Functional Neuromodulation, GlaxoSmithKline, the National Football League, the National Institute on Aging, NIMH, Novartis, Ortho-McNeil, Pfizer, and the Weinberg Foundation; he has served as a consultant or adviser for AbbVie, Adlyfe, Astellas, AstraZeneca, Avanir, Bristol-Myers Squibb, Eisai, Elan, Eli Lilly, Forest, Genentech, GlaxoSmithKline, Janssen, Lundbeck, Merck, Merz, the NFL Players Association, the NFL Benefits Office, Novartis, Orion, Otsuka, Pfizer, Supernus, Takeda, Wyeth, and Zinfandel; and he has received honoraria or travel support from Forest, GlaxoSmithKline, Health Monitor, and Pfizer. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2018",
month = jun,
doi = "10.1176/appi.ajp.2018.18010048",
language = "English (US)",
volume = "175",
pages = "493--494",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "6",
}